fosfomycin, interesting alternative drug for treatment of urinary tract infections created by multiple drug resistant and extended spectrum β-lactamase producing strains
نویسندگان
چکیده
background and objectives: the emergence and spread of multidrug resistant (mdr) and extended spectrum β-lactamase (esbl) producing strains reduces the number of effective drugs that can be used for treatment. the aim of this study was to evaluate the susceptibility profile of enterobacteriaceae isolated from utis, specifically mdr and esbl producing strains, to fosfomycin and other antibiotics. materials and methods: the study was performed during a 6 month period (february 2014 to august 2015). a total of 219 non-duplicate urinary isolates of enterobacteriaceae were collected. identification and susceptibility testing was done according to standard microbiological procedures and the kirby- bauer test, respectively. based on the results obtained from susceptibility testing, mdr bacteria were recovered and identification of esbl production was done according to clsi recommendation. results: isolates of e. coli and klebsiella spp.were responsible for 80.8% and 12.8% of patients with utis respectively. the rates of resistance to ampicillin, cefazolin, nalidixic acid, trimethoprim-sulfamethoxazole were 86.3%, 79.4%, 68.5% and 63.9% respectively. in contrast, high sensitivity rates were detected to fosfomycin, amikacin and amoxicillin-clavulanic acid with 97.3%, 91.8% and 80.8%, respectively. of all isolates, 167 (76.3%) were detected as mdr and 75 (34.2%) as esbl producing strains. conclusion: the rate of antibiotic resistance among uropathogens enterobacteriaceae is remarkably high. the most effec- tive antibiotic was fosfomycin. moreover, susceptibility to fosfomycin is over 90% for mdr and esbl producer isolates. therefore, fosfomycin can be a good option for treating utis.
منابع مشابه
Fosfomycin, interesting alternative drug for treatment of urinary tract infections created by multiple drug resistant and extended spectrum β-lactamase producing strains
BACKGROUND AND OBJECTIVES The emergence and spread of multidrug resistant (MDR) and extended spectrum β-lactamase (ESBL) producing strains reduces the number of effective drugs that can be used for treatment. The aim of this study was to evaluate the susceptibility profile of Enterobacteriaceae isolated from UTIs, specifically MDR and ESBL producing strains, to fosfomycin and other antibiotics....
متن کاملAmikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli
BACKGROUND/AIMS The number of urinary tract infections (UTIs) caused by extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) is increasing. In an outpatient setting, there are limited therapeutic options to treat ESBL-producing pathogens. We evaluated the outcomes of amikacin outpatient parenteral antibiotic therapy (OPAT) for UTIs caused by ESBL-EC in patients not pre-treated wit...
متن کاملPrevalence of Multiple Drug Resistant Clinical Isolates of Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae in Southeast Iran
Background: Multidrug resistance and production of extended spectrum β-lactamases (ESBLs) by enteric gram-negative rods in hospitals and community continue to be worsened. We aimed to characterize the multidrug resistance and determine the prevalence of ESBL production by clinical isolates of Enterobacteriaceae in southeast Iran. Methods: Gram-negative bacteria isolated from clinical samples of...
متن کاملRisk Factors for Community Acquired Extended-Spectrum Β-lactamase (ESBL) Producing Enterobacteriaceae Urinary Tract Infections (UTIs)
متن کامل
Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections.
Fosfomycin tromethamine (FT) is effective in vitro in extended spectrum beta-lactamase (ESBL)-producing Escherichia coli strains. The aim of this study was to evaluate the effect of FT in the treatment of ESBL-producing E. coli-related lower urinary tract infection. All patients were aged >18; had dysuria or problems with frequency or urgency in passing urine; had >20leukocytes/mm(3) in urine s...
متن کاملExtended-spectrum β-lactamase-producing enterobacteriaceae in community-acquired urinary tract infections in São Luís, Brazil
The number of ESBL-producing Enterobacteriaceae in community-acquired urinary tract infections worldwide is probably underestimated because of the technical difficulties encountered with their detection. In this study, out of 5,672 urine samples analyzed, 916 were positive for uropathogens, 472 of them being enterobacteria of which 7.6% produced β-lactamases. Analysis of the isolated from 36 pa...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
iranian journal of microbiologyجلد ۸، شماره ۲، صفحات ۱۲۵-۱۳۱
کلمات کلیدی
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023